Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
Procter & Gamble Corporate Headquarters with American flag.
October 27, 2025 3:31 PM 3 min read

P&G Holds Its Premium As Analysts Cite Durable Growth Beyond Near-Term Tariff Hits

by Triveni Kothapalli Benzinga Staff Writer
Follow

ArticleFeaturedTickersList12345!!!

The Procter & Gamble Company (NYSE:PG) outperformed expectations on organic sales and margins in the first quarter of fiscal 2026 while keeping its full-year topline and EPS guidance unchanged.

Bank of America analysts led by Peter T. Galbo reiterated their Buy rating and raised the price forecast to $175 from $174, citing steady execution and innovation-led share gains despite near-term consumption moderation.

P&G's consumption trends softened through the quarter, slowing from about 2.4% to 1.8-1.9%, with near-term growth expected to be between 1.5% and 2%.

Also Read: Procter & Gamble Warns $800M Rise In Tariff Costs, Picks New CEO

P&G is responding to heightened competitive promotions by emphasizing innovation-led growth, rolling out new products such as Tide liquid and Tide EVO in laundry care and Pampers and Luvs in baby care.

Six of P&G's seven regions maintained or expanded market share, supported by a 7% gain in Latin America. Europe remained stable, while Asia Pacific and the Middle East saw slight declines. In Greater China, sales grew 5%, with momentum broadening beyond SK-II and strong double-digit gains in baby care.

Updated Tariff and Cost Expectations

Analysts highlighted that P&G now expects $500 million in tariff-related costs, down from $750 million previously and $1 billion at fiscal fourth-quarter earnings, due to certain material exclusions like Brazilian eucalyptus pulp, adjusted sourcing and potential further upside (India/Metamucil).

Second Half Growth Rebound Anticipated

The brokerage noted that second quarter 2026 is likely to mark the softest growth period of the year, given tough comparisons with last year's port strikes that notably affected Family Care. However, management anticipates a rebound in the second half, supported by ongoing innovation, restructuring benefits, and improving supply chain.

Despite competitors' heightened promotional activity in select categories, P&G is expected to stay disciplined in pursuing quality-led growth.

The analyst noted that the company's superiority model remains resilient as tariff and supply headwinds subside.

Revised Financial Estimates and Valuation

Bank of America slightly raised its EPS estimates for 2026, 2027 and 2028 to $7.00, $7.35 and $7.75, respectively, from $6.94, $7.30 and $7.70 earlier, reflecting the flow-through of the first-quarter beat but partially offset by softer second-quarter assumptions.

The brokerage now forecasts second-quarter organic sales growth of 0.5% versus a prior estimate of 1.5%, and 2026 organic growth of 1.6%, down from a previous forecast of 2%. Gross margin for the second quarter is expected to contract by 50 basis points, with EPS of $1.87, down from $1.91 earlier.

Revenue is forecast to rise to $86.73 billion in 2026, and for 2027, Bank of America expects sales to edge up further to $88.25 billion, followed by $89.81 billion in 2028.

Bank of America's Buy rating on P&G and price forecast of $175, based on a 24.5x CY26E P/E multiple.

The brokerage said the 20% valuation premium for household and personal care peers reflects P&G's long-term growth potential, despite short-term tariff and restructuring pressures.

Price Action: PG shares were trading lower by 0.80% to $151.27 at last check Monday.

Read Next:

  • What’s Going On With Verizon Stock?

Photo by Jonathan Weiss via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
Analyst ColorNewsPrice TargetReiterationTop StoriesAnalyst RatingsMoversTrading IdeasExpert Ideaswhy it's moving
PG Logo
PGProcter & Gamble Co
$151.40-0.24%
Overview
PG Logo
PGProcter & Gamble Co
$151.40-0.24%
Overview
Comments
Loading...